Archean Chemical Industries Limited DCF Valuation

ACI · Chemicals · Current price ₹478.6

Full stock page
DocStoX fair value
₹472
medium confidence · 55/100
Current price
₹470
Upside to fair value
+0.3%
Estimate range
₹425 – ₹519
5Y profit growth
+9.6%
Model it yourself — DCF Calculator
Opens pre-filled with Archean Chemical Industries Limited's latest numbers.

Archean Chemical Industries Limited cash-flow valuation

Our engine did not use a discounted-cash-flow model for Archean Chemical Industries Limited. It routes each business to the methods that suit it, and a DCF is a poor lens where cash-flow forecasts are fragile or the business is capital-structure driven. The methods it did use, and why, are set out below. Our published estimate is ₹472.

Try your own assumptions

Prefer to build the discounted cash flow yourself? The DCF calculator below opens pre-filled with Archean Chemical Industries Limited's reported free cash flow, net debt and share count, so you can set your own growth and discount rate.

How we got this fair value

Every number below is part of the same estimate for Archean Chemical Industries Limited. Nothing here is a target price or a forecast of where the share price will go.

Medium confidence55/100

Workable, with real gaps. Weigh it alongside your own view rather than on its own.

Estimate range ₹425 – ₹519

Why this method for this business

Normalized earnings and EV/EBITDA are the most appropriate models for a cyclical specialty chemical company like ACI, as they reflect mid-cycle earnings power and through-cycle valuation multiples.

The models behind the number

Each method is weighted by how well its inputs held up for this company.

Normalized earnings (mid-cycle EV/EBITDA)
₹47270% weight

Cyclical valued off mid-cycle earnings and a through-cycle EV/EBITDA (§6.6)

EV / EBITDA(not enough data)

required inputs missing

  • relative_pe: Not used due to lack of reliable sector P/E data for cyclical chemicals
  • discounted_cash_flow: Not used as the business is highly cyclical and cash flows are volatile

What was missing

  • Lack of historical EV/EBITDA multiple data for precise normalization
  • Limited analyst coverage for accurate P/E multiple benchmarking

What drives it

7 inputs, grouped by how strong each claim is
ReportedRead from filings or market data. Verifiable, not our opinion.
Revenue (TTM)
1,081 ₹ cr

computed

Net debt
448.8 ₹ cr

computed

Shares outstanding
12,32,00,000

computed

AssumptionA forward input the model chose. Reasonable people can disagree here.
EBITDA margin (cycle median)
35%

computed (≤5y median)

Through-cycle EV/EBITDA
16.55×

own-history (median of 5y)

DerivedFalls out of the inputs above: a model output, not an independent input.
Mid-cycle EBITDA
378.3 ₹ cr

computed

Enterprise value
6,263.2 ₹ cr

computed

Who computed this

A language model (qwen3:8b) selects the valuation method and the judgement inputs for Archean Chemical Industries Limited: which models suit the business, the moat, the growth and margin assumptions. It does not produce the number. The fair value itself is computed in Python by a deterministic engine (version 2026.08.1) from those inputs, so the same inputs always give the same result and every figure above can be traced to a source.

Estimated 14 Sept 2026. Re-run as new financials and news arrive.

How we value stocks

We estimate what a business is worth from its own economics: cash flows, returns on capital, and a multiple justified by its quality, rather than from where the share price has been. A fair value estimate is a view, not a verdict, and it is only as good as the inputs listed above.

Read the full fair-value methodology

More on Archean Chemical Industries Limited

DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.